Free Trial
NASDAQ:NVOS

Novo Integrated Sciences (NVOS) Stock Price, News & Analysis

$0.0008 +0.00 (+33.33%)
As of 11:16 AM Eastern

About Novo Integrated Sciences Stock (NASDAQ:NVOS)

Advanced

Key Stats

Today's Range
$0.0006
▼
$0.0008
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.03
Volume
2,613 shs
Average Volume
6,733 shs
Market Capitalization
$15.78 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novo Integrated Sciences, Inc. is a healthcare company focused on providing multidisciplinary medical and wellness services. Through its operating businesses, the company has offered services such as physical rehabilitation, chiropractic care, massage therapy, kinesiology, naturopathic medicine, acupuncture and related health services.

The company has also pursued technology-enabled healthcare initiatives, including telehealth and digital healthcare solutions, as well as the development or commercialization of medical and wellness products. Its service model is designed to support patients through coordinated care delivered by healthcare professionals across multiple disciplines.

Novo Integrated Sciences has historically conducted operations primarily in Canada through a network of clinics and healthcare-related businesses. Publicly available company information has described its activities as evolving through acquisitions, partnerships and new healthcare initiatives. Specific current leadership and operating details may change over time and are not included here where reliable information is unavailable.

AI Generated. May Contain Errors.

Receive NVOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVOS Stock News Headlines

I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
See More Headlines

NVOS Stock Analysis - Frequently Asked Questions

Novo Integrated Sciences' stock was trading at $0.0027 at the beginning of the year. Since then, NVOS stock has decreased by 70.4% and is now trading at $0.0008.

Novo Integrated Sciences's stock reverse split on the morning of Tuesday, November 7th 2023.The 1-10 reverse split was announced on Tuesday, November 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of NVOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novo Integrated Sciences investors own include Tesla (TSLA), Workhorse Group (WKHS), T2 Biosystems (TTOO), Avalo Therapeutics (AVTX), Canopy Growth (CGC), Cybin (HELP) and SeaStar Medical (ICU).

Company Calendar

Today
11/13/2026
Fiscal Year End
8/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
NASDAQ:NVOS
CIK
1138978
Fax
N/A
Employees
170
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
($0.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.17 million
Net Margins
-121.55%
Pretax Margin
-121.32%
Return on Equity
-93.07%
Return on Assets
-46.28%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
0.37
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$13.52 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.77 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
19,730,000
Free Float
17,678,000
Market Cap
$15.78 thousand
Optionable
Not Optionable
Beta
5.30

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:NVOS) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners